QIAGEN N.V. (QGEN)
$21.64
0.13 (+0.60%)
| CAPS Rating |
|
|---|---|
| Open | $22.01 |
| Previous Close | $21.51 |
| Daily Range | $21.53 - $22.06 |
| 52-Week Range | $14.02 - $23.58 |
| Market Cap | $5B |
| P/E Ratio | 23.64 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,228,068 |
| Average Daily Volume | 942,000 |
QGEN
VS S&P 500 (SPY)
How do you think QGEN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
QGEN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
QGEN News and Commentary
- Roche Gets FDA Emergency Approval For Swine Flu Test – SmartMoney
- Seeking Alpha on Qiagen N.V. – Ockham-RazorWire
- This One's Growing Through the Recession – The Motley Fool
- 5 Stocks Ready for Liftoff – The Motley Fool
- Anticipating Active '09 for AspenBio Pharma – Blog at The Motley Fool
- Affymetrix Misses; Investors Panic – The Motley Fool
- A New Wave for Third Wave – The Motley Fool
- Affymetrix Expands – The Motley Fool
- Tuesday's Rocket Stocks – The Motley Fool
- Drugmaker Growth Without the FDA – The Motley Fool
- 4 Stocks Getting Taken Out – The Motley Fool
Related News and Articles
- How Do You Say 'Drug Development' in Mandarin? – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Pharma Researchers Need a Cure – The Motley Fool
- The Waters Aren't Flowing. Yet. – The Motley Fool
- Ugly, but Still Built for Growth – The Motley Fool
- Taking the Drug Industry's Temperature – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
RSS Headlines
Fool UK
